Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial (Q37094993)
Jump to navigation
Jump to search
scientific article published on 08 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial |
scientific article published on 08 July 2016 |
Statements
1 reference
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial (English)
1 reference
Andreas Schneeweiss
1 reference
Alexandra von Au
1 reference
Eva Milloth
1 reference
Ingo Diel
1 reference
Stefan Stefanovic
1 reference
Andre Hennigs
1 reference
Markus Wallwiener
1 reference
Joerg Heil
1 reference
Michael Golatta
1 reference
Joachim Rom
1 reference
Christof Sohn
1 reference
Florian Schuetz
1 reference
Christoph Domschke
1 reference
8 July 2016
1 reference
1 reference
4173-4180
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference